Dizal Pharmaceuticals: Clinical Trials & Research Profile
Biopharma Industry (Global / Institutional) · Primary Focus: Oncology and Hematology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Global / Institutional) |
| Primary Therapeutic Area | Oncology and Hematology |
| Active Phase II & III Studies | 15 active (11 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 23 (2 with California sites) |
| Completed vs Early-Stopped Studies | 7 completed / 1 stopped (4.4% stop rate) |
| Median Closed Enrollment | 58 participants |
| FDA Drugs@FDA Original Approvals | 0 all-time (0 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 93.8% named hospital slots |
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk